Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Risk of incident diabetes after COVID-19 infection: A systematic review and meta-analysis
Honghao Lai, Manli Yang, Mingyao Sun, et al.
Metabolism (2022) Vol. 137, pp. 155330-155330
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Low Vitamin D Levels Are Associated With Long COVID Syndrome in COVID-19 Survivors
Luigi di Filippo, Stefano Frara, Fabrizio Nannipieri, et al.
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 108, Iss. 10, pp. e1106-e1116
Open Access | Times Cited: 64
COVID-19 and Bone Loss: A Review of Risk Factors, Mechanisms, and Future Directions
Amy Creecy, Olatundun D. Awosanya, Alexander Harris, et al.
Current Osteoporosis Reports (2024) Vol. 22, Iss. 1, pp. 122-134
Open Access | Times Cited: 17
SARS-CoV-2 and its Multifaceted Impact on Bone Health: Mechanisms and Clinical Evidence
Alexander Harris, Amy Creecy, Olatundun D. Awosanya, et al.
Current Osteoporosis Reports (2024) Vol. 22, Iss. 1, pp. 135-145
Open Access | Times Cited: 16
Endothelial Extracellular Vesicles Enriched in microRNA-34a Predict New-Onset Diabetes in Coronavirus Disease 2019 (COVID-19) Patients: Novel Insights for Long COVID Metabolic Sequelae
Pasquale Mone, Stanislovas S. Jankauskas, Maria Virginia Manzi, et al.
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 389, Iss. 1, pp. 34-39
Open Access | Times Cited: 8
Does COVID-19 Infection Increase the Risk of Diabetes? Current Evidence
Rachel Wong, Emily K.Y. Lam, Carolyn T. Bramante, et al.
Current Diabetes Reports (2023) Vol. 23, Iss. 8, pp. 207-216
Open Access | Times Cited: 20
Mechanisms and clinical relevance of the bidirectional relationship of viral infections with metabolic diseases
Nikolaos Perakakis, Hani Harb, Benjamin G. Hale, et al.
The Lancet Diabetes & Endocrinology (2023) Vol. 11, Iss. 9, pp. 675-693
Open Access | Times Cited: 18
Incidence of type 2 diabetes before and during the COVID-19 pandemic in Naples, Italy: a longitudinal cohort study
Raffaele Izzo, Daniela Pacella, Valentina Trimarco, et al.
EClinicalMedicine (2023) Vol. 66, pp. 102345-102345
Open Access | Times Cited: 16
Diabetes Mellitus, Energy Metabolism, and COVID-19
Caterina Conte, Elisa Cipponeri, Michael Roden
Endocrine Reviews (2023) Vol. 45, Iss. 2, pp. 281-308
Open Access | Times Cited: 15
The relationship between SARS-CoV-2 infection and type 1 diabetes mellitus
Cyril Debuysschere, Magloire Pandoua Nekoua, Enagnon Kazali Alidjinou, et al.
Nature Reviews Endocrinology (2024) Vol. 20, Iss. 10, pp. 588-599
Closed Access | Times Cited: 5
Antidiabetic agent use and clinical outcomes in patients with diabetes hospitalized for COVID-19: a systematic review and meta-analysis
Jordan N. Keels, Isabella R. McDonald, Christopher S. Lee, et al.
Frontiers in Endocrinology (2025) Vol. 15
Open Access
The rise in incidence of pediatric type 2 diabetes during the COVID-19 pandemic and the virus as a potential causative factor
Andrew Kanouse, Joanna Fishbein, Parissa Salemi
Diabetes Epidemiology and Management (2025), pp. 100258-100258
Open Access
Future prevalence of type 2 diabetes in Germany: a projection until 2040 including incidence trends observed during the SARS-CoV-2 pandemic
Thaddäus Tönnies, Dina Voeltz, Stephan D. Voss, et al.
Frontiers in Epidemiology (2025) Vol. 5
Open Access
Hemoglobin A1c in youth and adults with cystic fibrosis related diabetes decreases after elexacaftor-tezacaftor-ivacaftor
Colleen Wood, Amir Moheet, Tim Vigers, et al.
Journal of Cystic Fibrosis (2025)
Closed Access
COVID-19, Nutrients and Lifestyle Eating Behaviors: A Narrative Review
Giovanni Cangelosi, Sara Morales Palomares, Paola Pantanetti, et al.
Diseases (2024) Vol. 12, Iss. 8, pp. 193-193
Open Access | Times Cited: 4
Long-Term effects of COVID-19: a review of current perspectives and mechanistic insights
Christian Lenz, Mary Slack, Kimberly M. Shea, et al.
Critical Reviews in Microbiology (2023) Vol. 50, Iss. 3, pp. 315-328
Open Access | Times Cited: 11
Prevalence and risk of new-onset diabetes mellitus after COVID-19: a systematic review and meta-analysis
Chiara Bellia, Aikaterini Andreadi, Ilenia D’Ippolito, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 11
Impact of COVID-19 on risks and deaths of non-communicable diseases in the Western Pacific region
Xiaoyue Xu, Zumin Shi, Lihui Zhou, et al.
The Lancet Regional Health - Western Pacific (2023) Vol. 43, pp. 100795-100795
Open Access | Times Cited: 11
Spatiotemporal association between COVID-19 incidence and type 1 diabetes incidence among children and adolescents: a register-based ecological study in Germany
Joachim Rosenbauer, Anna Stahl‐Pehe, Christina Baechle, et al.
Frontiers in Endocrinology (2024) Vol. 14
Open Access | Times Cited: 2
Visual analysis of hotspots and trends in long COVID research based on bibliometric
Zongqiang Lai, Tao Pu, Jun Li, et al.
Heliyon (2024) Vol. 10, Iss. 2, pp. e24053-e24053
Open Access | Times Cited: 2
Long COVID and gut candidiasis: What is the existing relationship?
Filippo Bistagnino, Davide Pizzi, Filippo Mantovani, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 37, pp. 4104-4114
Closed Access | Times Cited: 2
Multiple influences of the COVID-19 pandemic on children with diabetes: Changes in epidemiology, metabolic control and medical care
Stefano Zucchini, Andrea Scozzarella, Giulio Maltoni
World Journal of Diabetes (2023) Vol. 14, Iss. 3, pp. 198-208
Open Access | Times Cited: 5
The risk for celiac disease after Covid-19 infection
Jesper Lexner, Ylva Lindroth, Klas Sjöberg
BMC Gastroenterology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 5
COVID-19 infection and incident diabetes in American Indian and Alaska Native people: a retrospective cohort study
James W. Keck, Mary E. Lacy, Sara Bressler, et al.
The Lancet Regional Health - Americas (2024) Vol. 33, pp. 100727-100727
Open Access | Times Cited: 1
New-Onset Diabetes Mellitus after COVID-19: Combined Effects of SARS-CoV-2 Variants, Molecular Mimicry, and m6A RNA Methylation
Jorge Luis Batista-Roche, Marian Mirabent-Casals, Dahís Manzanares, et al.
COVID (2024) Vol. 4, Iss. 4, pp. 481-494
Open Access | Times Cited: 1
The effects of the first UK lockdown for the COVID-19 pandemic on primary-care-recorded cancer and type-2 diabetes mellitus records: A population-based quasi-experimental time series study
S.J. Price, Sarah Bailey, William Hamilton, et al.
Cancer Epidemiology (2024) Vol. 91, pp. 102605-102605
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top